• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

BMC Geriatr . Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis

tetano

Editor, Senior Moderator
BMC Geriatr


. 2021 May 19;21(1):321.
doi: 10.1186/s12877-021-02261-3.
Clinical features and outcomes of COVID-19 in older adults: a systematic review and meta-analysis


Sunny Singhal[SUP] 1 [/SUP], Pramod Kumar[SUP] 1 [/SUP], Sumitabh Singh[SUP] 2 [/SUP], Srishti Saha[SUP] 3 [/SUP], Aparajit Ballav Dey[SUP] 4 [/SUP]



Affiliations

Abstract

Background: Few studies have focused on exploring the clinical characteristics and outcomes of COVID-19 in older patients. We conducted this systematic review and meta-analysis to have a better understanding of the clinical characteristics of older COVID-19 patients.
Methods: A systematic search of PubMed and Scopus was performed from December 2019 to May 3rd, 2020. Observational studies including older adults (age ? 60 years) with COVID-19 infection and reporting clinical characteristics or outcome were included. Primary outcome was assessing weighted pooled prevalence (WPP) of severity and outcomes. Secondary outcomes were clinical features including comorbidities and need of respiratory support.
Result: Forty-six studies with 13,624 older patients were included. Severe infection was seen in 51% (95% CI- 36-65%, I[SUP]2[/SUP]-95%) patients while 22% (95% CI- 16-28%, I[SUP]2[/SUP]-88%) were critically ill. Overall, 11% (95% CI- 5-21%, I[SUP]2[/SUP]-98%) patients died. The common comorbidities were hypertension (48, 95% CI- 36-60% I[SUP]2[/SUP]-92%), diabetes mellitus (22, 95% CI- 13-32%, I[SUP]2[/SUP]-86%) and cardiovascular disease (19, 95% CI - 11-28%, I[SUP]2[/SUP]-85%). Common symptoms were fever (83, 95% CI- 66-97%, I[SUP]2[/SUP]-91%), cough (60, 95% CI- 50-70%, I[SUP]2[/SUP]-71%) and dyspnoea (42, 95% CI- 19-67%, I[SUP]2[/SUP]-94%). Overall, 84% (95% CI- 60-100%, I[SUP]2[/SUP]-81%) required oxygen support and 21% (95% CI- 0-49%, I[SUP]2[/SUP]-91%) required mechanical ventilation. Majority of studies had medium to high risk of bias and overall quality of evidence was low for all outcomes.
Conclusion: Approximately half of older patients with COVID-19 have severe infection, one in five are critically ill and one in ten die. More high-quality evidence is needed to study outcomes in this vulnerable patient population and factors affecting these outcomes.

Keywords: Comorbidities; Coronavirus; Mortality; Severe illness; Symptoms.
 
Back
Top Bottom